Loading...
XJPX
2796
Market cap38mUSD
Dec 05, Last price  
530.00JPY
1D
1.53%
1Q
4.74%
Jan 2017
0.38%
IPO
4.38%
Name

Pharmarise Holdings Corp

Chart & Performance

D1W1MN
XJPX:2796 chart
P/E
—
P/S
0.09
EPS
—
Div Yield, %
1.13%
Shrs. gr., 5y
-1.96%
Rev. gr., 5y
4.47%
Revenues
63.51b
+16.60%
18,576,785,00020,007,602,00023,416,897,00026,825,000,00029,607,057,00033,357,066,00038,221,039,00039,506,082,00048,511,570,00052,949,000,00054,562,000,00051,728,000,00051,030,000,00052,324,000,00051,608,000,00052,030,000,00054,466,000,00063,508,000,000
Net income
-367m
L+4.56%
96,525,000222,508,000276,576,000562,978,000685,818,000958,001,000369,094,000227,892,000382,195,0007,000,000-208,000,00023,000,000577,000,000426,000,000447,000,000333,000,000-351,000,000-367,000,000
CFO
1.31b
-51.69%
1,480,409,0001,272,516,000807,366,000942,417,0002,283,834,0001,618,239,0001,306,120,0003,405,093,000-272,758,0002,103,000,0001,330,000,000895,000,0001,572,000,0001,945,000,000713,000,0002,520,000,0002,714,000,0001,311,000,000
Dividend
May 29, 20250 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.
URL
https://www.pharmarise.com/
IPO date
Feb 01, 2007
Employees
1,555
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑052024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT